Lion Street Advisors LLC Sells 165 Shares of CVS Health Co. (NYSE:CVS)

Lion Street Advisors LLC decreased its holdings in shares of CVS Health Co. (NYSE:CVS) by 2.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,074 shares of the pharmacy operator’s stock after selling 165 shares during the period. Lion Street Advisors LLC’s holdings in CVS Health were worth $445,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Ables Iannone Moore & Associates Inc. bought a new stake in CVS Health during the 4th quarter worth approximately $32,000. First Community Trust NA boosted its position in shares of CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after buying an additional 302 shares during the last quarter. Creekmur Asset Management LLC purchased a new stake in CVS Health in the 4th quarter valued at $34,000. Steph & Co. lifted its stake in CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after acquiring an additional 288 shares in the last quarter. Finally, ORG Partners LLC boosted its holdings in CVS Health by 11,840.0% during the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 592 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Performance

NYSE:CVS opened at $66.63 on Friday. The company has a market capitalization of $83.65 billion, a price-to-earnings ratio of 11.71, a PEG ratio of 0.93 and a beta of 0.54. CVS Health Co. has a 1-year low of $52.77 and a 1-year high of $83.25. The business has a 50 day moving average of $59.12 and a 200 day moving average of $61.15. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The company had revenue of $91.23 billion during the quarter, compared to analysts’ expectations of $91.41 billion. During the same period in the prior year, the business posted $2.21 EPS. CVS Health’s quarterly revenue was up 2.6% compared to the same quarter last year. On average, sell-side analysts predict that CVS Health Co. will post 6.51 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.99%. The ex-dividend date is Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is presently 46.75%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Barclays raised CVS Health from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $63.00 to $82.00 in a research report on Thursday. Wells Fargo & Company upped their price target on CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a research report on Monday, August 12th. Evercore ISI lifted their price objective on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday. Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a research report on Tuesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a report on Friday, August 9th. Nine equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $75.26.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.